Promotions & Moves
Related Searches:
Filter by:
646 - 660 of 1175 results
November 16, 2009
Robert A. Stewart has joined Watson Pharmaceuticals in the newly created position of senior vice president, Global Operations, effective immediately. Also, Thomas R. Russillo has been named executive vice president, Global Generics.
Read More »
November 13, 2009
Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire, effective February 28, 2010.
Read More »
November 4, 2009
Pramod Gupta, Ph.D. has been appointed vice president of quality and chief scientific officer, Coldstream Laboratories, Inc. (CLI).
Read More »
November 3, 2009
Kenneth A. Berlin has been appointed president and chief executive officer, Rosetta Genomics, Ltd., and has been recommended to serve on the company’s board of directors.
Read More »
October 30, 2009
R. Todd Joyce has been named senior vice president and chief financial officer of Watson Pharmaceuticals, effective immediately.
Read More »
October 26, 2009
HollisterStier Contract Manufacturing and sister organization, Draxis Pharma, have appointed Steven Rowan as vice president of business development, Jubilant Organosys Contract Manufacturing North America.
Read More »
October 23, 2009
John L. Workman has been appointed executive vice president and chief financial officer, Omnicare, Inc., effective November 18th.
Read More »
October 22, 2009
Dr. Hui Cai has been appointed as vice president of business development, WuXi PharmaTech.
Read More »
October 19, 2009
Dr. Robert Garnick has joined Peregrine Pharmaceuticals as the head of regulatory affairs
Read More »
October 14, 2009
Susan Kramer, Dr. P.H., has been named vice president, Project and Alliance Management at XOMA
Read More »
October 13, 2009
Bruce J. Seeley has been named executive vice president, commercial at Seattle Genetics.
Read More »
October 12, 2009
David Wolton has been named vice president manufacturing at CMC Biologics
Read More »
October 9, 2009
Paul S. Changelian, Ph.D. and Peter L. Toogood, Ph.D. have been appointed to Lycera Corp.'s drug development team.
Read More »
October 6, 2009
Dr. Ganesh Iyer has been appointed president and chief executive officer, OctAlgos Therapeutics Inc., effective immediately.
Read More »
October 1, 2009
Troy W. McCall, Ph.D. has been promoted from chief operating officer to chief executive officer at Premier Research Group, effective immediately.
Read More »
646 - 660 of 1175 results
